The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform
Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
